Trial Profile
Maternal antibodies against pertussis in neonates .
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2014
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms Matab2
- 13 Sep 2014 New trial record